FDA Form 483 (Inspectional Observations) - Top Violations 2013
Environmental Monitoring Considerations Nancy Roscioli, Ph.D. Don Hill and Associates, Inc.
A Risk-Based Approach for Investigating Environmental Monitoring Excursions
6.PARENTERAL
2-5a_MediaFill.ppt
Sterile Drug Process Inspections FDA Anita R. Michael Pharmaceutical Investigator.
Media Fill Protocol Luisa Stoppa Manufacture of sterile medicines – Advanced workshop for SFDA GMP inspectors Nanjing, the People’s Republic of China –
DISCOVER DEVELOP MANUFACTURE CMO’s Challenges and Strategies in Aseptic Manufacturing Jixing Wang, Ph.D. GMP Summit 2014 September 25-26, 2014 Valencia.
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
Culture Media
